ENTRY       D03230                      Drug
NAME        Insulin human (USP/INN);
            Insulin human (genetical recombination) (JP18);
            Insulin human (biosynthesis) (JAN);
            Insulin human (synthesis) (JAN);
            Humulin (TN)
PRODUCT     AFREZZA (Mannkind Corporation)
            HUMULIN (Eli Lilly and Company)
            MYXREDLIN (Baxter Healthcare Corporation)
FORMULA     C257H383N65O77S6
EXACT_MASS  5803.6376
MOL_WEIGHT  5807.5702
SEQUENCE    (A chain) Gly Ile Val Glu Gln Cys Cys Thr Ser Ile Cys Ser Leu Tyr
            Gln Leu Glu Asn Tyr Cys Asn
            (B chain) Phe Val Asn Gln His Leu Cys Gly Ser His Leu Val Glu Ala
            Leu Tyr Leu Val Cys Gly Glu Arg Gly Phe Phe Tyr Thr Pro Lys Thr
            (Disulfide bridge: A6-A11, A7-B7, A20-B19)
  TYPE      Peptide
CLASS       Antidiabetic agent
             DG01636  Insulin preparation
              DG01802  Human insulin
            Metabolizing enzyme inducer
             DG01637  CYP1A2 inducer
REMARK      Therapeutic category: 2492
            ATC code: A10AB01 A10AC01 A10AD01 A10AE01 A10AF01
            Product: D03230<JP/US>
EFFICACY    Antidiabetic, Insulin receptor agonist
  DISEASE   Diabetes mellitus [DS:H00408 H00409]
TARGET      INSR (CD220) [HSA:3643] [KO:K04527]
  PATHWAY   hsa04910(3643)  Insulin signaling pathway
            hsa04930(3643)  Type II diabetes mellitus
INTERACTION CYP induction: CYP1A2 [HSA:1544]
STR_MAP     map07051  Antidiabetics
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A10 DRUGS USED IN DIABETES
               A10A INSULINS AND ANALOGUES
                A10AB Insulins and analogues for injection, fast-acting
                 A10AB01 Insulin (human)
                  D03230  Insulin human (USP/INN) &lt;JP/US&gt;
                A10AC Insulins and analogues for injection, intermediate-acting
                 A10AC01 Insulin (human)
                  D03230  Insulin human (USP/INN) &lt;JP/US&gt;
                A10AD Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting
                 A10AD01 Insulin (human)
                  D03230  Insulin human (USP/INN) &lt;JP/US&gt;
                A10AE Insulins and analogues for injection, long-acting
                 A10AE01 Insulin (human)
                  D03230  Insulin human (USP/INN) &lt;JP/US&gt;
                A10AF Insulins and analogues for inhalation
                 A10AF01 Insulin (human)
                  D03230  Insulin human (USP/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Blood Glucose Regulators
              Insulins
               Insulin, Rapid-acting
                Insulin Oral Inhalation
                 D03230  Insulin human (USP/INN)
               Insulin, Short-acting
                Insulin Human (Regular)
                 D03230  Insulin human (USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              24  Hormones
               249  Miscellaneous
                2492  Pancreatic hormones
                 D03230  Insulin human (USP/INN); Insulin human (genetical recombination) (JP18); Insulin human (biosynthesis) (JAN); Insulin human (synthesis) (JAN)
            Drug groups [BR:br08330]
             Antidiabetic agent
              DG01636  Insulin preparation
               DG01802  Human insulin
                D03230  Insulin human
             Metabolizing enzyme inducer
              DG01637  CYP1A2 inducer
               D03230  Insulin human
            Drug classes [BR:br08332]
             Antidiabetic agent
              DG01636  Insulin preparation
               D03230  Insulin human
            Target-based classification of drugs [BR:br08310]
             Protein kinases
              Receptor tyrosine kinases (RTK)
               INSR family
                INSR (CD220)
                 D03230  Insulin human (USP/INN) &lt;JP/US&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D03230  Insulin human (genetical recombination)
              D03230  Insulin human (genetical recombination) injection
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D03230
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D03230
DBLINKS     CAS: 11061-68-0
            PubChem: 17397383
///
